genomics
News,Singapore,Investments,Asia,HealthTech
Mayo Clinic Laboratories invests in Pathology Asia and LifeStrands Genomics
Mayo Clinic Laboratories has invested in Singapore-based Pathology Asia Holdings and LifeStrands Genomics to expand advanced diagnostics and precision medicine across Asia Pacific.
September 23, 2026
Ofiniti to acquire ZeroNorth eBDN business as it expands in Singapore
September 23, 2026
Ofiniti to acquire ZeroNorth eBDN business as it expands in Singapore
September 23, 2026




